Unicorn Nest Logo

Sambrinvest

sambrinvest.be
Charleroi, Belgium
Venture Capital
Active
Total investments

31

Average round size

9M

Portfolio companies

26

Rounds per year

0.82

Lead investments

4

Follow on index

0.13

Exits

1

Areas of investment
BiotechnologyInternetSoftwareInformation TechnologyHealth CareBig DataMedicalCloud Data ServicesLife SciencePharmaceutical

Investor highlights

Industry focus
ManufacturingFoodtechBiotech/Life SciencesAgriculture
Stage focus
Series ASeries BSeries DSeries CSeries E

Discover reliable insights

Find relevant VC investors, identify key contacts and secure funding opportunities.

Find investors

Investments analytics

Analytics

Total investments
31
Lead investments
4
Exits
1
Rounds per year
0.82
Follow on index
0.13
Investments by industry
  • Biotechnology (11)
  • Health Care (10)
  • Information Technology (8)
  • Medical (5)
  • Pharmaceutical (4)
    • Show 40 more
Investments by region
  • Belgium (24)
  • France (3)
  • Spain (1)
  • Netherlands (2)
Peak activity year
2019

Discover reliable insights

Leverage validated data, identify key contacts and secure funding opportunities for your business.
Sign Up

Quantitative data

Avg. startup age at the time of investment
6
Group Appearance index
0.90

Need more data?

Get access to full data about investors, including their team, contact information, and historic data.

Upgrade

Latest deals

Company nameDeal dateIndustryDeal stageDeal sizeLocation
Amyl Therapeutics03 Jun 2021Biotechnology, Health Care, Medical, Life ScienceEarly Stage Venture10MLiège, Liege, Belgium
EsoBiotec30 Sep 2021BiotechnologySeed3MBrabant Wallon, Mont-saint-guibert, Belgium
SavvyCard24 Oct 2011Automotive, Real Estate, Software, Consumer, SaaS, Marketing, AdvertisingSeed300KUnited States, Florida, Saint Petersburg
How we get our data

At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).

Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.